Expression systems of human β-defensins: vectors, purification and biological activities
- 537 Downloads
Human beta-defensins are 2–5 kDa, cationic, microbicidal peptides, which represent the first-line host defense against several Gram-negative and Gram-positive bacteria, fungi and viruses. They contain a conserved disulfide-bridge pattern of three pairs of intramolecular cystine bonds. The well-known public health problem related with the growing number of multiresistant bacteria has driven research to look for novel antibiotics, such beta-defensins and a feasible way to produce them. Heterologous expression of beta-defensins could be one way to generate large quantities of beta-defensins for clinical research; however, heterologous expression of beta-defensins has some biochemical problems, such toxicity toward the host cell, peptide degradation by proteolytic cell enzymes, size, folding constrains and low recombinant peptide yields. In this communication, several heterologous systems for producing human beta-defensins are reviewed.
KeywordsAntibiotic Bacteria Defensin Heterologous expression Antimicrobial Peptide
This work was supported by grants from the Dirección General de Asuntos del Personal Académico (DGAPA-UNAM) IN220809 to GC. Ligia Luz Corrales is recipient of a Ph.D. scholarship (331398/229367) from CONACyT.
- Aerts AM, Thevissen K, Bresseleers SM, Sels J, Wouters P, Cammue BPA, François IEJA (2007) Arabidopsis thaliana plants expressing human-defensin-2 are more resistant to fungal attack: functional homology between plant and human defensins. Plant Cell Rep 26:1391–1398. doi: 10.1007/s00299-007-0329-4 CrossRefPubMedGoogle Scholar
- Lehmann J, et al. (2002) Expression of human β-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis 20. doi: 10.1186/1471-2334-2-20
- Li-gang S, Xi-cheng L, You-yong L, Gen-yu W, Wen-mei L (2007) Soluble expression of active human-defensin-3 in Escherichia coli and its effects on the growth of host cells. Chin Med J 120:708–713Google Scholar
- Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB, Tack BF, Vogel HJ (2002) The solution structures of the human-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277:8279–8289. doi: 10.1074/jbc.M108830200 CrossRefPubMedGoogle Scholar
- Schwaab M, Hansen S, Pearson MD, Shagdarsuren S, Dazert S (2009) Human-defensins—at the front line of the peritonsillar abscess. Eur J Clin Microbiol Infect Dis. doi: 10.1007/s10096-008-0695-z
- Valore EV, Ganz T (1997) Antibacterial peptide protocols. In: W-M Shafer (ed) Methods in molecular biology (1 edn). Humana Press Inc., Tokowa, NJ, USAGoogle Scholar
- Wei Q, Kim YS, Seo JH, Jang WS, Lee IH, Cha HJ (2005) Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli. Appl Environ Microbiol 71. doi: 10.1128/AEM.71.9.5038-5043.2005